Technetium labelled peptides
US9259496B2 · kind B2 · utility
4Cited by
5References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2012 |
| Grant date | Feb 16, 2016 |
| Priority date | — |
| Expiry date | Mar 17, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K51/088
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to technetium imaging agents comprising radiolabeled c-Met binding peptides suitable for SPECT or PET imaging in vivo. The c-Met binding peptides are labelled via chelator conjugates. Also disclosed are pharmaceutical compositions, methods of preparation of the agents and compositions, plus methods of in vivo imaging using the compositions, especially for use in the diagnosis of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.